Silvant Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.57M Sell
5,422
-51
-0.9% -$25.7K 0.09% 123
2025
Q4
$2.56M Hold
5,473
0.09% 121
2025
Q3
$2.33M Sell
5,473
-309
-5% -$120K 0.08% 119
2025
Q2
$2.22M Hold
5,782
0.08% 124
2025
Q1
$2M Hold
5,782
0.09% 124
2024
Q4
$1.74M Hold
5,782
0.07% 129
2024
Q3
$2.35M Sell
5,782
-740
-11% -$271K 0.1% 114
2024
Q2
$2.1M Hold
6,522
0.09% 115
2024
Q1
$2.18M Hold
6,522
0.1% 114
2023
Q4
$1.77M Sell
6,522
-15
-0.2% -$3.71K 0.09% 117
2023
Q3
$1.61M Hold
6,537
0.1% 124
2023
Q2
$1.98M Sell
6,537
-2
-0% -$556 0.11% 109
2023
Q1
$1.72M Hold
6,539
0.11% 113
2022
Q4
$1.57M Sell
6,539
-15
-0.2% -$3.36K 0.11% 117
2022
Q3
$1.21M Buy
+6,554
New +$1.31M 0.08% 122

Other funds holding HCA

Silvant Capital Management's HCA Position: Q1 2026 in Review

Silvant Capital Management reduced its HCA Healthcare (HCA) stake by 0.93% in Q1 2026, selling an estimated $25.7K and leaving 5,422 shares worth $2.57M. The position accounts for 0.09% of the portfolio, ranked #123.

Silvant Capital Management first reported a position in HCA in Q3 2022 and has held it in 15 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Silvant Capital Management held 5,422 shares of HCA Healthcare worth $2.57M as of Q1 2026.
  • Silvant Capital Management sold 51 HCA Healthcare shares in Q1 2026, an estimated $25.7K.
  • HCA Healthcare made up 0.09% of Silvant Capital Management's portfolio in Q1 2026, its #123 holding.
  • Silvant Capital Management first reported a position in HCA Healthcare in Q3 2022 and has held it in 15 quarters since.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Silvant Capital Management's 13F filing for Q1 2026, filed 14 May 2026.